Overview

Update
Acquisitions
2 Acquisitions
IPO / Stock
Went Public on Apr 1, 2006 / LSE:ENTL
Headquarters:
San Mateo, CA
Description:
Entelos is a provider of predictive biosimulation for drug discovery and development.
Founders:
,
Categories:
Therapeutics, Health Care, Biotechnology
Website:
http://www.entelos.com
Social:

Company Details

Update

Entelos is the leading provider of predictive biosimulation for drug discovery and development. We provide advanced biosimulation capabilities that make discovery more efficient and increase clinical success.

For over 15 years, we have enabled R&D organizations to predict better paths to success by simulating systems biology. Our solutions include mechanism-based, mathematical models; virtual patients and populations; biosimulation software; and biosimulation expertise.

Funding Rounds (3) - $14.6M

Update
DateAmount / RoundValuationLead InvestorInvestors
Jun, 2013undisclosed amount / Undisclosed2
Sep, 2001undisclosed amount / Venture1
May, 2000$14.6M / Series B5

Acquisitions (2)

Update
DateAcquiredAmount
Aug 30, 2007$39.1M in Stock
May 27, 2005Unknown

Offices/Locations (1)

Update
  • Office

    2121 South El Camino Real

    Suite 600

    San Mateo, CA 94403

    USA

Images (1)

Update

Add Current Team

Add Board Members and Advisors

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos